These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 108938)

  • 21. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis.
    Wolde K; Lema E; Roscigno G; Abdi A
    Ethiop Med J; 1992 Apr; 30(2):63-8. PubMed ID: 1345030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
    Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
    Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of tuberculous meningitis: role of short-course chemotherapy.
    Phuapradit P; Vejjajiva A
    Q J Med; 1987 Mar; 62(239):249-58. PubMed ID: 3659258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlled trial of intermittent regimens of rifampicin plus isoniazid for pulmonary tuberculosis in Singapore.
    Lancet; 1975 Dec; 2(7945):1105-9. PubMed ID: 53598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A therapeutic trial of a combination of 3 essential drugs in a short course of chemotherapy in tuberculosis. Results 6 months after the end of treatment].
    Agounitestane D; Chiheb M; Khaled S; Ait Khaled N; Boulahbal F; Chaulet P
    Rev Mal Respir; 1990; 7(3):209-13. PubMed ID: 2114029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of unfixed continuation phase short-course chemotherapy].
    Xiao C; Fu Y; Li Z
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.
    Trastotenojo MS; Wiroreno B; Santosa ; Soemantri AG; Hendarto T; Singgih Y
    Paediatr Indones; 1983; 23(11-12):240-9. PubMed ID: 6678404
    [No Abstract]   [Full Text] [Related]  

  • 29. Controlled therapeutic trial with the combination rifampicin-isoniazid given for six months to previously untreated patients with pulmonary tuberculosis.
    Dubra F
    Bull Int Union Tuberc; 1972 Feb; 47():37-40. PubMed ID: 4562016
    [No Abstract]   [Full Text] [Related]  

  • 30. Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
    Lin TP; Suo J; Lee CN; Lee JJ; Yang SP
    Am Rev Respir Dis; 1987 Oct; 136(4):808-10. PubMed ID: 3310770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative trial of thiacetazone with isoniazid and paraaminosalicyclic acid (PAS) with isoniazid in the treatment of pulmonary tuberculosis in Nigerians.
    Onadeko BO; Sofowora EO
    J Trop Med Hyg; 1975 Sep; 78(9):201-5. PubMed ID: 57244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short course chemotherapy for pulmonary tuberculosis with duration for 6 months after sputum negative conversion. (Report 1)--Report of the 19--20th A series of controlled trial of chemotherapy--(author's transl)].
    Kekkaku; 1979 Jan; 54(1):51-61. PubMed ID: 107362
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 2. Second report: the results from 12 to 24 months.
    Who Collaborating Centre For Tuberculosis Chemotherapy
    Bull World Health Organ; 1973; 48(2):155-65. PubMed ID: 4578361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A controlled trial of six months chemotherapy in pulmonary tuberculosis. First Report: results during chemotherapy. British Thoracic Association.
    Br J Dis Chest; 1981 Apr; 75(2):141-53. PubMed ID: 7023526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tolerability and efficacy of a 6-month antituberculosis regimen containing rifampicin, isoniazid and pyrazinamide.
    Kleeberg HH; Swart DJ; Carey SM
    S Afr Med J; 1983 Oct; 64(18):693-6. PubMed ID: 6623275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland.
    Snider DE; Rogowski J; Zierski M; Bek E; Long MW
    Am Rev Respir Dis; 1982 Feb; 125(2):265-7. PubMed ID: 7065534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled clinical trial of four 6-month regimens of chemotherapy for pulmonary tuberculosis. Second report. Second East African/British Medical Research Council Study.
    Am Rev Respir Dis; 1976 Sep; 114(3):471-5. PubMed ID: 788570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlled clinical trial of two 6-month regimens of chemotherapy in the treatment of pulmonary tuberculosis. Tanzania/British Medical Research Council Study.
    Am Rev Respir Dis; 1985 May; 131(5):727-31. PubMed ID: 3890640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results at 5 years of a controlled comparison of a 6-month and a standard 18-month regimen of chemotherapy for pulmonary tuberculosis.
    Am Rev Respir Dis; 1977 Jul; 116(1):3-8. PubMed ID: 69411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-course (6 month) cooperative tuberculosis study in Poland: results 18 months after completion of treatment.
    Zierski M; Bek E; Long MW; Snider DE
    Am Rev Respir Dis; 1980 Dec; 122(6):879-89. PubMed ID: 7006476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.